康缘药业跌2.01%，成交额9313.95万元，主力资金净流出248.13万元

Core Viewpoint - Kangyuan Pharmaceutical's stock has experienced fluctuations, with a current price of 16.06 CNY per share and a market capitalization of 9.093 billion CNY, reflecting a year-to-date increase of 17.91% [1] Group 1: Stock Performance - As of November 17, Kangyuan Pharmaceutical's stock price decreased by 2.01% during the trading session [1] - The stock has seen a 1.90% increase over the last five trading days and a 3.81% increase over the last twenty days, while it has declined by 9.01% over the last sixty days [1] Group 2: Financial Performance - For the period from January to September 2025, Kangyuan Pharmaceutical reported a revenue of 2.343 billion CNY, a year-on-year decrease of 24.66% [2] - The net profit attributable to shareholders for the same period was 200 million CNY, reflecting a year-on-year decrease of 44.10% [2] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Kangyuan Pharmaceutical increased by 17.20% to 40,500 [2] - The average number of circulating shares per shareholder decreased by 14.68% to 13,969 shares [2] - The company has distributed a total of 949.8 million CNY in dividends since its A-share listing, with 345 million CNY distributed over the last three years [3]